Shearman & Sterling successfully represented Arch Chemicals before the French and German competition authorities in connection to Lonza’s $1.4 billion acquisition of all outstanding shares of Arch. The merger creates one of the world’s largest microbial control companies.

The following Shearman & Sterling team advised Arch on this transaction: partner Stephen Mavroghenis (Brussels-Antitrust) and associates Ief Daems (Brussels-Antitrust), Francesco Carloni (Brussels-Antitrust) and Mark English (Brussels-Antitrust).